Janssen Search
Search results
Accelerating Hope for Children
Accelerating Hope for Children For nearly 20 years, Janssen, the pharmaceutical companies of Johnson & Johnson (J&J), have been working to bring hope to the millions of children with serious diseases worldwide. With a science- and evidence-based ...
Johnson & Johnson strengthens pipeline to lead in atopic dermatitis with the completion of the acquisition of Yellow Jersey Therapeutics, gaining ownership of NM26
Jul 11, 2024 NM26 is a Phase 2-ready, first-in-class bispecific antibody targeting two clinically proven pathways in atopic dermatitis (AD) The Company is leveraging a multi-pathway approach to transform treatment in atopic dermatitis and other immune ...
Robert Yang, Ph.D.
ROBERT YANG, PH.D. GLOBAL HEAD DATA SCIENCES & PREVENTION BIOMARKERS WORLD WITHOUT DISEASE ACCELERATOR As Global Head, Data Sciences & Prevention Biomarkers, World Without Disease Accelerator (WWDA), Robert leads a team focused on developing ...
Pauline McNulty, Ph.D.
PAULINE MCNULTY, PH.D. VICE PRESIDENT PATIENT REPORTED OUTCOMES, GLOBAL MARKET ACCESS GLOBAL COMMERCIAL STRATEGY ORGANIZATION Pauline McNulty is Vice President, Patient Reported Outcomes, Global Market Access in the Global Commercial Strategy Organization ...
How to Lead with Impact as Healthcare Manufacturers and Innovators in a Post-COVID World
How to Lead with Impact as Healthcare Manufacturers and Innovators in a Post-COVID World " Unprecedented times… Uncertain circumstances… Unlike anything we’ve seen before." We’ve all had more than our fill of those "un" phrases over ...
Partner with Global Public Health
Partner With Us for Global Public Health Janssen is responsible for a growing portfolio of pharmaceutical products and services to address the world’s greatest unmet public health needs. Key focus areas include tuberculosis, HIV/AIDS, and neglected ...
Janssen Never Stops
Our Commitment Watch this video and you'll have a better idea of what we do every day to prevent, treat, cure, and stop some of the most devastating and complex diseases of our time. FOR U.S. PATIENTS PATIENT RESOURCES ACCESS AND AFFORDABILITY ...
About Janssen Diagnostics
About Precision Medicine and Janssen Diagnostics Advances in science and technology are opening new horizons in healthcare and hold the promise of truly precise, personalized medicine. Today’s healthcare systems demand improved medical outcomes at lower ...
Darren Snellgrove
DARREN SNELLGROVE VICE PRESIDENT GROUP FINANCE WORLDWIDE PHARMACEUTICALS Darren Snellgrove is Vice President, Group Finance, Worldwide Pharmaceuticals. In this position, Darren will provide strategic and financial leadership to the Global Pharmaceuticals ...
Thomas M. Luby, Ph.D.
Thomas Luby, Ph.D. is a Senior Director of New Ventures at Johnson & Johnson Innovation, Boston, focusing on early investments and collaborations in Neuroscience, Cardiovascular & Metabolism and Infectious Disease. Prior to joining the Johnson ...